Cargando…

Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis

There is an increasing prevalence of chronic kidney disease (CKD), which associates with the development of interstitial fibrosis. Pericytes (perivascular fibroblasts) provide a major source of α-SMA-positive myofibroblasts that are responsible for the excessive deposition of extracellular matrix. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Bijkerk, Roel, Au, Yu Wah, Stam, Wendy, Duijs, Jacques M. G. J., Koudijs, Angela, Lievers, Ellen, Rabelink, Ton J., van Zonneveld, Anton Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421975/
https://www.ncbi.nlm.nih.gov/pubmed/30914951
http://dx.doi.org/10.3389/fphar.2019.00215
_version_ 1783404333592739840
author Bijkerk, Roel
Au, Yu Wah
Stam, Wendy
Duijs, Jacques M. G. J.
Koudijs, Angela
Lievers, Ellen
Rabelink, Ton J.
van Zonneveld, Anton Jan
author_facet Bijkerk, Roel
Au, Yu Wah
Stam, Wendy
Duijs, Jacques M. G. J.
Koudijs, Angela
Lievers, Ellen
Rabelink, Ton J.
van Zonneveld, Anton Jan
author_sort Bijkerk, Roel
collection PubMed
description There is an increasing prevalence of chronic kidney disease (CKD), which associates with the development of interstitial fibrosis. Pericytes (perivascular fibroblasts) provide a major source of α-SMA-positive myofibroblasts that are responsible for the excessive deposition of extracellular matrix. In order to identify pericyte long non-coding RNAs (lncRNAs) that could serve as a target to decrease myofibroblast formation and counteract the progression of kidney fibrosis we employed two models of experimental kidney injury, one focused on kidney fibrosis (unilateral ureteral obstruction; UUO), and one focused on acute kidney injury that yields kidney fibrosis in the longer term (unilateral ischemia-reperfusion injury; IRI). This was performed in FoxD1-GC;tdTomato stromal cell reporter mice that allowed pericyte fate tracing. Tomato red-positive FoxD1-derivative cells of control and injured kidneys were FACS-sorted and used for lncRNA and mRNA profiling yielding a distinctive transcriptional signature of pericytes and myofibroblasts with 244 and 586 differentially expressed lncRNAs (>twofold, P < 0.05), in the UUO and IRI models, respectively. Next, we selected two differentially expressed and conserved lncRNAs, Rian (RNA imprinted and accumulated in nucleus) and Miat (Myocardial infarction associated transcript), and explored their potential regulatory role in myofibroblast formation through knockdown of their function with gapmers. While Miat was upregulated in myofibroblasts of UUO and IRI in mice, gapmer silencing of Miat attenuated myofibroblast formation as evidenced by decreased expression of α-SMA, col1α1, SMAD2, and SMAD3, as well as decreased α-SMA and pro-collagen-1α1 protein levels. In contrast, silencing Rian, which was found to be downregulated in kidney myofibroblast after IRI and UUO, resulted in increased myofibroblast formation. In addition, we found microRNAs that were previously linked to Miat (miR-150) and Rian (14q32 miRNA cluster), to be dysregulated in the FoxD1-derivative cells, suggesting a possible interaction between miRNAs and these lncRNAs in myofibroblast formation. Taken together, lncRNAs play a regulatory role in myofibroblast formation, possibly through interacting with miRNA regulation, implicating that understanding their biology and their modulation may have the potential to counteract the development of renal fibrosis.
format Online
Article
Text
id pubmed-6421975
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64219752019-03-26 Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis Bijkerk, Roel Au, Yu Wah Stam, Wendy Duijs, Jacques M. G. J. Koudijs, Angela Lievers, Ellen Rabelink, Ton J. van Zonneveld, Anton Jan Front Pharmacol Pharmacology There is an increasing prevalence of chronic kidney disease (CKD), which associates with the development of interstitial fibrosis. Pericytes (perivascular fibroblasts) provide a major source of α-SMA-positive myofibroblasts that are responsible for the excessive deposition of extracellular matrix. In order to identify pericyte long non-coding RNAs (lncRNAs) that could serve as a target to decrease myofibroblast formation and counteract the progression of kidney fibrosis we employed two models of experimental kidney injury, one focused on kidney fibrosis (unilateral ureteral obstruction; UUO), and one focused on acute kidney injury that yields kidney fibrosis in the longer term (unilateral ischemia-reperfusion injury; IRI). This was performed in FoxD1-GC;tdTomato stromal cell reporter mice that allowed pericyte fate tracing. Tomato red-positive FoxD1-derivative cells of control and injured kidneys were FACS-sorted and used for lncRNA and mRNA profiling yielding a distinctive transcriptional signature of pericytes and myofibroblasts with 244 and 586 differentially expressed lncRNAs (>twofold, P < 0.05), in the UUO and IRI models, respectively. Next, we selected two differentially expressed and conserved lncRNAs, Rian (RNA imprinted and accumulated in nucleus) and Miat (Myocardial infarction associated transcript), and explored their potential regulatory role in myofibroblast formation through knockdown of their function with gapmers. While Miat was upregulated in myofibroblasts of UUO and IRI in mice, gapmer silencing of Miat attenuated myofibroblast formation as evidenced by decreased expression of α-SMA, col1α1, SMAD2, and SMAD3, as well as decreased α-SMA and pro-collagen-1α1 protein levels. In contrast, silencing Rian, which was found to be downregulated in kidney myofibroblast after IRI and UUO, resulted in increased myofibroblast formation. In addition, we found microRNAs that were previously linked to Miat (miR-150) and Rian (14q32 miRNA cluster), to be dysregulated in the FoxD1-derivative cells, suggesting a possible interaction between miRNAs and these lncRNAs in myofibroblast formation. Taken together, lncRNAs play a regulatory role in myofibroblast formation, possibly through interacting with miRNA regulation, implicating that understanding their biology and their modulation may have the potential to counteract the development of renal fibrosis. Frontiers Media S.A. 2019-03-11 /pmc/articles/PMC6421975/ /pubmed/30914951 http://dx.doi.org/10.3389/fphar.2019.00215 Text en Copyright © 2019 Bijkerk, Au, Stam, Duijs, Koudijs, Lievers, Rabelink and van Zonneveld. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Bijkerk, Roel
Au, Yu Wah
Stam, Wendy
Duijs, Jacques M. G. J.
Koudijs, Angela
Lievers, Ellen
Rabelink, Ton J.
van Zonneveld, Anton Jan
Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis
title Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis
title_full Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis
title_fullStr Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis
title_full_unstemmed Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis
title_short Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis
title_sort long non-coding rnas rian and miat mediate myofibroblast formation in kidney fibrosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421975/
https://www.ncbi.nlm.nih.gov/pubmed/30914951
http://dx.doi.org/10.3389/fphar.2019.00215
work_keys_str_mv AT bijkerkroel longnoncodingrnasrianandmiatmediatemyofibroblastformationinkidneyfibrosis
AT auyuwah longnoncodingrnasrianandmiatmediatemyofibroblastformationinkidneyfibrosis
AT stamwendy longnoncodingrnasrianandmiatmediatemyofibroblastformationinkidneyfibrosis
AT duijsjacquesmgj longnoncodingrnasrianandmiatmediatemyofibroblastformationinkidneyfibrosis
AT koudijsangela longnoncodingrnasrianandmiatmediatemyofibroblastformationinkidneyfibrosis
AT lieversellen longnoncodingrnasrianandmiatmediatemyofibroblastformationinkidneyfibrosis
AT rabelinktonj longnoncodingrnasrianandmiatmediatemyofibroblastformationinkidneyfibrosis
AT vanzonneveldantonjan longnoncodingrnasrianandmiatmediatemyofibroblastformationinkidneyfibrosis